16 hours ago · INDIANAPOLIS, Feb. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its financial results for the fourth quarter of 2024 and detailed 2025 financial …

16 hours ago · INDIANAPOLIS, Feb. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its financial results for the fourth quarter of 2024 and detailed 2025 financial …

16 hours ago · Eli Lilly and Company (NYSE: LLY) today announced its financial results for the fourth quarter of 2024 and detailed 2025 financial guidance. ... Revenue in Q4 2024 increased …

15 hours ago · Global pharmaceutical company Eli Lilly (NYSE:LLY) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 44.7% year on year to $13.53 billion. ... Eli Lilly …

7 hours ago · Eli Lilly (NYSE: LLY) Q4 2024 Earnings Call Feb 06, 2025, 10:00 a.m. ET. Contents: ... Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 …

16 hours ago · INDIANAPOLIS, Feb. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its financial results for the fourth quarter of 2024 and detailed 2025 financial …

The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.

16 hours ago · Eli Lilly (LLY) reported strong Q4 2024 financial results with revenue increasing 45% to $13.53 billion, primarily driven by Mounjaro and Zepbound sales.Q4 EPS grew 102% …

13 hours ago · Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 …

8 hours ago · As shown in the Eli Lilly 11, we combine U.S. Incretin Analogs Market through 45% compared to Q4 2023. We increased 3 percentage points in share of market in Q4 2024.